Nov 12 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2015 Sep 30, 2014 Dec 31, 2015
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 19 mln 7 mln 105 mln
(+179.7 pct) (+275.0 pct)
Operating loss 698 mln loss 523 mln loss 1.60
Recurring loss 599 mln loss 436 mln loss 1.51
Net loss 601 mln loss 446 mln loss 1.51
EPS loss 65.46 yen loss 48.73 yen loss 164.80 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T
((Tokyo Headline News Desk +813 6441 1812))